Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
11.7%
% of XLV's 60 holdings also in XPH
17.1%
% of XPH's 41 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.5% | 3.7% | 3.7% |
|
ELI LILLY & CO | 12.3% | 3.7% | 3.7% |
|
MERCK & CO. INC. | 4.3% | 3.5% | 3.5% |
|
PFIZER INC | 2.7% | 3.6% | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.3% | 3.7% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to XPH
|
UNITEDHEALTH GROUP INC | 9.0% |
|
ELI LILLY & CO | 8.6% |
|
ABBVIE INC | 6.9% |
|
ABBOTT LABORATORIES | 4.3% |
|
JOHNSON & JOHNSON | 3.7% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
INTUITIVE SURGICAL INC | 3.3% |
|
AMGEN INC | 3.1% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
GILEAD SCIENCES INC | 2.6% |
XLV Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -3.9% |
 |
PERRIGO CO | -3.8% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
ELANCO ANIMAL HEALTH, INC. | -3.7% |
|
CORCEPT THERAPEUTICS INC | -3.7% |
|
AXSOME THERAPEUTICS, INC. | -3.7% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.6% |
|
ORGANON & CO. | -3.6% |
|
ROYALTY PHARMA PLC CLASS A | -3.5% |
|
JAZZ PHARMACEUTICALS PLC | -3.4% |